SEC charges Sientra, ex-CEO Zeini with misleading investors

You are here: Home > Central Coast Health Watch > Current Article

SEC charges Sientra, ex-CEO Zeini with misleading investors

By Marissa Nall / Friday, September 28th, 2018 / Comments Off on SEC charges Sientra, ex-CEO Zeini with misleading investors

Breast implant manufacturer Sientra’s headquarters in Goleta. The Securities and Exchange Commission has charged Goleta breast implant maker Sientra and its former CEO Hani Zeini with misleading investors in a 2015 stock offering that netted the company gross proceeds of $66 million. The company agreed to settle the charges without admitting or denying the findings,…

This article is only available to Business Times subscribers

Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
Check the STATUS of your Subscription Account.